Training at Washington University in St. Louis

Eight positions are available on a competitive basis each year in the Hematology-Oncology Fellowship at Washington University in St. Louis. One additional position is available for the Hematology Focused Fellowship Training Program (HFFTP) in Hematology Track.

The Hematology-Oncology Fellowship Program is committed to fostering a diverse and inclusive community which is critical to creating an environment of collaborative learning and teamwork. Please visit the Washington University Diversity and Inclusion website for details regarding the ongoing University-wide programs and initiatives.


  • This application cycle is for the academic year beginning on July 1, 2024.
  • Applications will be accepted beginning July 5, 2023 for the fellowship year beginning on July 1, 2024.  The application and all supporting documentation must be submitted by August 2, 2023 at 11:59 CST.
  • All applicants will be notified of a decision regarding interviews on or around August 22, 2023.
  • Interviews will be held  9/5/2023, 9/14/2023, 9/18/2023, 9/20/2023, 9/26/2023, 9/29/2023  and 10/9/2023.  All interviews will be held virtually.


To be eligible for the Hematology-Oncology Fellowship/Hematology Track, you must have successfully completed three years of an accredited postgraduate training program in internal medicine in the United States or Canada and have passed United States Medical Licensing Examination (USMLE) Step 3 by January of the year you would begin the program, to ensure licensure. 

Our program accepts H-1B and J-1 visas for transfer, but does not sponsor new visa applications.

How to Apply

  • All applications to the Hematology-Oncology Fellowship Program and/or Hematology Track must be submitted through ERAS, the Electronic Residency Application Service.
  • Applications will be reviewed once they include the following minimum requirements:

    • ERAS Application and Curriculum Vitae
    • Letter of recommendation from the residency Program Director (Letter from the Division Chair will be accepted if more than 2 years out of Residency)
    • At least 2 additional letters of recommendation
    • Medical school transcripts
    • MSPE (if applicable)
    • USMLE transcripts
    • Personal statement
    • ECFMG Status Report (for International Medical Graduates)

Applications are reviewed as they are received. All applicants will receive a notification regarding the status of their applications on or around August 22, 2023. This year, our program will be using Thalamus scheduling software to manage interview schedules. Please be sure to add to your safe senders list to ensure you receive all notifications from our program regarding invitations. 


Q: Does your program accept candidates that require visa sponsorship?

A: Yes, our program accepts and sponsors candidates that currently hold J-1 or H-1B visas, as long as there is enough time remaining on the visa to complete training. We are not able to initiate applications for a new visa.

Q: Can I interview with a specific physician?

A: We try our best to match candidates with requested physician interviewers, but cannot guarantee all specific requests owing to scheduling difficulties. Whenever possible, we will match candidates with interviewers that share their clinical interests. If we are unable to accommodate a request, we are happy to put you in contact with our physicians via email.

Q: How do I apply?

A: Applications for the Washington University School of Medicine Fellowship Program are accepted via ERAS, which has two tracks: Hematology and Medical Oncology Track (8 positions) and Hematology Track (1 position).

Q: Can I apply to both tracks?

A: Yes, prospective candidates can apply to either or both tracks based on their academic and clinical interests. Each track is listed separately in the match.  

  • The Hematology-Oncology Fellowship is NRMP Program Code 1353155F0 and is listed as Hematology and Oncology/Clinical.
  • The Hematology Focused Fellowship Training Program (HFFTP) is NRMP Program Code 1353155F1 and is listed as Hematology and Oncology/Hematology.